Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 3
2008 3
2012 1
2013 2
2014 3
2016 6
2017 8
2018 3
2019 3
2020 4
2021 3
2022 2
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Future lines of research on phase angle: Strengths and limitations.
Bellido D, García-García C, Talluri A, Lukaski HC, García-Almeida JM. Bellido D, et al. Rev Endocr Metab Disord. 2023 Jun;24(3):563-583. doi: 10.1007/s11154-023-09803-7. Epub 2023 Apr 12. Rev Endocr Metab Disord. 2023. PMID: 37043140 Free PMC article. Review.
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, Öhman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF; EXSCEL Study Group. Holman RR, et al. N Engl J Med. 2017 Sep 28;377(13):1228-1239. doi: 10.1056/NEJMoa1612917. Epub 2017 Sep 14. N Engl J Med. 2017. PMID: 28910237 Free PMC article. Clinical Trial.
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial.
Aroda VR, Rosenstock J, Wysham C, Unger J, Bellido D, González-Gálvez G, Takami A, Guo H, Niemoeller E, Souhami E, Bergenstal RM; LixiLan-L Trial Investigators. Aroda VR, et al. Among authors: bellido d. Diabetes Care. 2016 Nov;39(11):1972-1980. doi: 10.2337/dc16-1495. Epub 2016 Sep 20. Diabetes Care. 2016. PMID: 27650977 Clinical Trial.
Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes.
Gomez-Peralta F, Abreu C, Lecube A, Bellido D, Soto A, Morales C, Brito-Sanfiel M, Umpierrez G. Gomez-Peralta F, et al. Among authors: bellido d. Diabetes Ther. 2017 Oct;8(5):953-962. doi: 10.1007/s13300-017-0277-0. Epub 2017 Jul 18. Diabetes Ther. 2017. PMID: 28721687 Free PMC article. Review.
Ketogenic diets as treatment of obesity and type 2 diabetes mellitus.
Casanueva FF, Castellana M, Bellido D, Trimboli P, Castro AI, Sajoux I, Rodriguez-Carnero G, Gomez-Arbelaez D, Crujeiras AB, Martinez-Olmos MA. Casanueva FF, et al. Among authors: bellido d. Rev Endocr Metab Disord. 2020 Sep;21(3):381-397. doi: 10.1007/s11154-020-09580-7. Rev Endocr Metab Disord. 2020. PMID: 32803691 Review.
Epigenetic Effects of Healthy Foods and Lifestyle Habits from the Southern European Atlantic Diet Pattern: A Narrative Review.
Lorenzo PM, Izquierdo AG, Rodriguez-Carnero G, Fernández-Pombo A, Iglesias A, Carreira MC, Tejera C, Bellido D, Martinez-Olmos MA, Leis R, Casanueva FF, Crujeiras AB. Lorenzo PM, et al. Among authors: bellido d. Adv Nutr. 2022 Oct 2;13(5):1725-1747. doi: 10.1093/advances/nmac038. Adv Nutr. 2022. PMID: 35421213 Free PMC article. Review.
Position statement on efficiency of technologies for diabetes management.
Martín-Vaquero P, Martínez-Brocca MA, García-López JM; Grupo de Trabajo de Nuevas Tecnologías de la Sociedad Española; Grupo de Diabetes de la Sociedad Española de Endocrinología y Nutrición; Sociedad Española de Endocrinología Pediátrica. Martín-Vaquero P, et al. Endocrinol Nutr. 2014 Dec;61(10):e45-63. doi: 10.1016/j.endonu.2014.08.003. Endocrinol Nutr. 2014. PMID: 25453400 English, Spanish.
47 results